{
     "PMID": "11223016",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20010621",
     "LR": "20161124",
     "IS": "0006-8993 (Print) 0006-8993 (Linking)",
     "VI": "893",
     "IP": "1-2",
     "DP": "2001 Mar 2",
     "TI": "Does CDP-choline modulate phospholipase activities after transient forebrain ischemia?",
     "PG": "268-72",
     "AB": "Ten min forebrain ischemia/1-day reperfusion resulted in significant decreases in total phosphatidylcholine (PtdCho), phosphatidylinositol (PtdIns), and cardiolipin in gerbil hippocampus. CDP-choline restored cardiolipin levels, arachidonic acid content of PtdCho, partially but significantly restored total PtdCho, and had no effect on PtdIns. These data suggest that CDP-choline prevented the activation of phospholipase A(2) (rather than inhibiting phospholipase A(2) activity) but did not affect activities of PtdCho-phospholipases C and/or D, or phosphoinositide-phospholipase C. CDP-choline also provided significant protection for hippocampal CA(1) neurons.",
     "FAU": [
          "Rao, A M",
          "Hatcher, J F",
          "Dempsey, R J"
     ],
     "AU": [
          "Rao AM",
          "Hatcher JF",
          "Dempsey RJ"
     ],
     "AD": "Department of Neurological Surgery, H4-330, Clinical Science Center, 600 Highland Avenue, University of Wisconsin-Madison, Madison, WI 53792-3232, USA. adibhatl@neurosurg.wisc.edu",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0 (Cardiolipins)",
          "0 (Fatty Acids)",
          "0 (Isoenzymes)",
          "0 (Nootropic Agents)",
          "0 (Phosphatidylcholines)",
          "0 (Phosphatidylinositols)",
          "27YG812J1I (Arachidonic Acid)",
          "536BQ2JVC7 (Cytidine Diphosphate Choline)",
          "EC 3.1.- (Phospholipases)",
          "EC 3.1.1.32 (Phospholipases A)",
          "EC 3.1.4.- (Type C Phospholipases)",
          "EC 3.1.4.4 (Phospholipase D)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Arachidonic Acid/metabolism",
          "Cardiolipins/chemistry/metabolism",
          "Cytidine Diphosphate Choline/*administration & dosage",
          "Disease Models, Animal",
          "Enzyme Activation/drug effects",
          "Fatty Acids/analysis/metabolism",
          "Gerbillinae",
          "Hippocampus/drug effects/metabolism",
          "Injections, Intraperitoneal",
          "Ischemic Attack, Transient/*metabolism",
          "Isoenzymes/metabolism",
          "Male",
          "Nootropic Agents/*administration & dosage",
          "Phosphatidylcholines/chemistry/metabolism",
          "Phosphatidylinositols/chemistry/metabolism",
          "Phospholipase D/metabolism",
          "Phospholipases/*metabolism",
          "Phospholipases A/metabolism",
          "Prosencephalon/blood supply/*metabolism",
          "Type C Phospholipases/metabolism"
     ],
     "EDAT": "2001/02/27 10:00",
     "MHDA": "2001/06/22 10:01",
     "CRDT": [
          "2001/02/27 10:00"
     ],
     "PHST": [
          "2001/02/27 10:00 [pubmed]",
          "2001/06/22 10:01 [medline]",
          "2001/02/27 10:00 [entrez]"
     ],
     "AID": [
          "S0006-8993(00)03280-7 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 2001 Mar 2;893(1-2):268-72.",
     "term": "hippocampus"
}